Abstract
Since the nuclear disaster at the Fukushima Daiichi Nuclear Power Plant in 2011, radiation safety has become an important issue in nuclear medicine. Many structured guidelines or recommendations of various academic societies or international campaigns demonstrate important issues of radiation safety in nuclear medicine procedures. There are ongoing efforts to fulfill the basic principles of radiation protection in daily nuclear medicine practice. This article reviews important principles of radiation protection in nuclear medicine procedures. Useful references, important issues, future perspectives of the optimization of nuclear medicine procedures, and diagnostic reference level are also discussed.
Similar content being viewed by others
References
Choi YY, Jang SJ, Park SA, Kim SK, Song HC. KSNM Procedure Guidelines for 18F-Fluoro-2-Deoxyglucose PET/CT in Cancer Patients. 2013. http://ksnm.or.kr/info/contents/KSNM_F-18_FDG_PET-CT__2013-12-02.pdf. Accessed 12 Sep. 2015.
Song HC. Diagnostic reference levels in nuclear medicine imaging. Asia Ocean J Nucl Med Biol. 2015;3 Suppl 1:S55.
Song HC. Current global and Korean issues in safety of nuclear medicine procedures. Supplement for the 3rd International Symposium on the System of Radiological Protection (ICRP). 2015;S22.
Song HC. Diagnostic reference level in nuclear medicine. Supplement for the Annual Spring Meeting of the Korean Association for Radiation Protection. 2015:S47-61.
ICRP. ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21(1–3).
ICRP. ICRP publication 105: radiological protection in medicine. Ann ICRP. 2007;37(6).
ICRP. ICRP publication 73: radiological protection and safety in medicine. Ann ICRP. 1996;26(2).
Choosing Wisely. Five things physicians and patients should question. https://www.snmmi.org/ClinicalPractice/content.aspx?ItemNumber=9914. Accessed 12 Sep. 2015
Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, et al. Ablation with low-dose radioiodine and thyrotropin Alfa in thyroid cancer. N Engl J Med. 2012;366:1674–85.
Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med. 2012;366:1663–73.
EANM. EANM practice guidelines. http://www.eanm.org/publications/guidelines/index.php?navId=37. Accessed 12 Sep. 2015.
Oversight Committee for Guidance Document, SNMMI. SNMMI procedure standards. https://www.snmmi.org/ClinicalPractice/content.aspx?ItemNumber=6414. Accessed 12 Sep. 2015.
ICRP. ICRP publication 80: radiation dose to patients from radiopharmaceuticals (addendum to ICRP publication 53). Ann ICRP. 1998;28(3).
ICRP. ICRP publication 106: radiation dose to patients from radiopharmaceuticals (addendum 3 to ICRP publication 53). Ann ICRP. 2007;38(1–2).
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. Cancer J Clin. 2010;60:277–300.
Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380:499–505.
Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000;154:178–86.
Schauer DA, Linton OW. NCRP report no. 160, ionizing radiation exposure of the population of the united states, medical exposure-are we doing less with more, and is there a role for health physicists? Health Phys. 2009;97:1–5.
ICRP. ICRP publication 103. Ann ICRP. 2007;37(2–4).
National Electrical Manufacturers Association. Computed Tomography Dose Check. NEMA Standards Publication XR 25–2010.
ICRP. ICRP publication 94: release of patients after therapy with unsealed radionuclides. Ann ICRP. 2004;34(2).
Wellner U, Eschner W, Hillger HW, Schicha H. The exposure of relatives to patients of a nuclear medical ward after radioiodine therapy by inhalation of I-131 in their home. Nuklearmedizin. 1998;37:113–9.
IAEA. Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. IAEA Safety Standards for protecting people and the environment. General Safety Requirements Part 3. 1996.
ICRP. ICRP publication 84: pregnancy and medical radiation. Ann ICRP. 2000;30(1).
ICRP. ICRP publication 88: doses to the embryo and fetus from intakes of radionuclides by the mother. Ann ICRP. 2001;31(1–3).
Boice Jr JD, Miller RW. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology. 1999;59:227–33.
Wakeford R. Childhood leukaemia following medical diagnostic exposure to ionizing radiation in utero or after birth. Radiat Prot Dosim. 2008;132:166–74.
Brent RL. The effect of embryonic and fetal exposure to X-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16:347–68.
Laurier D, Jacob S, Bernier MO, Leuraud K, Metz C, Samson E, et al. Epidemiological studies of leukaemia in children and young adults around nuclear facilities: a critical review. Radiat Prot Dosim. 2008;132:182–90.
Chaparian A, Aghabagheri M. Fetal radiation doses and subsequent risks from X-ray examinations: should we be concerned? Iran J Reprod Med. 2013;11:899–904.
Wakeford R, Little MP. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int J Radiat Biol. 2003;79:293–309.
Wakeford R, Darby SC, Murphy MF. Temporal trends in childhood leukaemia incidence following exposure to radioactive fallout from atmospheric nuclear weapons testing. Radiat Environ Biophys. 2010;49:213–27.
Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL. Cancer mortality among atomic bomb survivors exposed in utero or as young children. Radiat Res. 1997;147:385–95.
ICRP. ICRP publication 53: radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1987;18(1).
Dose Datamed 2 (DDM2) Project report 2: diagnostic reference levels (DRLs) in Europe. 2010. http://ddmed.eu/_media/news:ddm2_project_report_part_2_final_rb_16052014.pdf. Accessed 12 Sep. 2015.
Vogiatzi S, Kipouros P, Chobis M. Establishment of dose reference levels for nuclear medicine in Greece. Radiat Prot Dosim. 2011;147:237–9.
Roch P, Aubert B. French diagnostic reference levels in diagnostic radiology, computed tomography and nuclear medicine: 2004–2008 review. Radiat Prot Dosim. 2013;154:52–75.
Etard C, Celier D, Roch P, Aubert B. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011. Radiat Prot Dosim. 2012;152:334–8.
Korpela H, Bly R, Vassileva J, Ingilizova K, Stoyanova T, Kostadinova I, et al. Recently revised diagnostic reference levels in nuclear medicine in Bulgaria and in Finland. Radiat Prot Dosim. 2010;139:317–20.
Brix G, Nosske D, Glatting G, Minkov V, Reske SN. A survey of PET activity in Germany during 1999. Eur J Nucl Med Mol Imaging. 2002;29:1091–7.
Hart D, Wall BF. UK nuclear medicine survey 2003–2004. Nucl Med Commun. 2005;26:937–46.
Shannoun F, Blettner M, Schmidberger H, Zeeb H. Radiation protection in diagnostic radiology. Dtsch Arztebl Int. 2008;105:41–6.
European Commission. Radiation protection 109: guidance on diagnostic reference levels (DRLs) for medical exposures. 1999. https://ec.europa.eu/energy/sites/ener/files/documents/109_en.pdf. Accessed 12 Sep. 2015.
Acknowledgments
This work was supported by the Nuclear Safety Research Program through the Korea Foundation of Nuclear Safety (KOFONS), granted financial resource from the Nuclear Safety and Security Commission (NSSC), Republic of Korea (Grant No. 1305033).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Sang-Geon Cho and Jahae Kim declare that they have no conflict of interest.
Ho-Chun Song has received research grants from the Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe) and the Nuclear Safety and Security Commission (NSSC), Republic of Korea (Grant No. 1305033).
Ethical Statement
The study was approved by an institutional review board or equivalent and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The institutional review board waived the need to obtain informed consent.
Rights and permissions
About this article
Cite this article
Cho, SG., Kim, J. & Song, HC. Radiation Safety in Nuclear Medicine Procedures. Nucl Med Mol Imaging 51, 11–16 (2017). https://doi.org/10.1007/s13139-016-0406-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-016-0406-0